The Salk professor developed the institute’s first neurobiology lab and used it to develop cell lines, describe amyloid β toxicity, and screen for compounds that protect against neurodegeneration.
The neuroscientist had been serving as interim president since Elizabeth Blackburn stepped down last year following gender discrimination lawsuits against the institute.